We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Avantor
AVTR
$9.27B
| $8.28M | 0.02% |
266,951
-2,892
| -1% | -$90.3K |
|
702
Carnival Corporation Ltd
CCL
$37.9B
| $8.27M | 0.02% |
998,822
-738,346
| -43% | -$10.8M |
|
703
Southern Copper
SCCO
$162B
| $8.26M | 0.02% |
181,102
-3,459
| -2% | -$197K |
|
704
Saia
SAIA
$9.55B
| $8.14M | 0.02% |
45,124
+15,434
| +52% | +$3.1M |
|
|
FRC
705
DELISTED
First Republic Bank
FRC
| $8.13M | 0.02% |
57,325
-3,659
| -6% | -$548K |
|
706
Fox Class A
FOXA
$26B
| $8.07M | 0.02% |
251,671
+202,366
| +410% | +$7.12M |
|
707
Chewy
CHWY
$9.26B
| $8.06M | 0.02% |
233,991
+93,524
| +67% | +$3M |
|
708
Constellation Energy
CEG
$98.5B
| $8.02M | 0.02% |
140,011
+23,103
| +20% | +$1.39M |
|
|
VISN
709
Vistance Networks Inc
VISN
$2.67B
| $7.96M | 0.02% |
1,356,613
+221,638
| +20% | +$1.55M |
|
710
AMC Entertainment Holdings
AMC
$2.15B
| $7.91M | 0.02% |
60,089
+42,054
| +233% | +$6.12M |
|
711
Fluor
FLR
$7.17B
| $7.86M | 0.02% |
+339,891
| New | +$9.13M |
|
712
Take-Two Interactive
TTWO
$47B
| $7.85M | 0.02% |
64,483
-29,415
| -31% | -$3.74M |
|
713
AES
AES
$10.5B
| $7.83M | 0.02% |
387,996
-267,022
| -41% | -$5.83M |
|
|
AL
714
DELISTED
Air Lease Corp
AL
| $7.58M | 0.02% |
235,525
-248,093
| -51% | -$9.4M |
|
715
Norfolk Southern
NSC
$75.3B
| $7.5M | 0.02% |
33,406
+9,693
| +41% | +$2.38M |
|
716
Baxter International
BAX
$14.4B
| $7.48M | 0.02% |
116,427
-146,070
| -56% | -$10.6M |
|
|
WCN
717
Waste Connections
WCN
$42.1B
| $7.44M | 0.02% |
60,146
-25,050
| -29% | -$3.25M |
|
718
Cincinnati Financial
CINF
$26.7B
| $7.41M | 0.02% |
63,675
-23,804
| -27% | -$3.02M |
|
719
Synaptics
SYNA
$4.16B
| $7.39M | 0.02% |
62,634
+28,735
| +85% | +$4.21M |
|
720
Alcoa
AA
$14B
| $7.37M | 0.02% |
162,983
-495,755
| -75% | -$32.2M |
|
721
Blackbaud
BLKB
$2.06B
| $7.35M | 0.02% |
129,270
-84,816
| -40% | -$4.93M |
|
722
ICU Medical
ICUI
$4.58B
| $7.35M | 0.02% |
44,696
-51,169
| -53% | -$9.85M |
|
723
Globus Medical
GMED
$11.5B
| $7.33M | 0.02% |
130,917
-49,113
| -27% | -$3.23M |
|
724
Dynatrace
DT
$14.4B
| $7.23M | 0.02% |
184,163
-40,685
| -18% | -$1.62M |
|
725
Choice Hotels
CHH
$4.6B
| $7.22M | 0.02% |
65,631
+34,373
| +110% | +$4.46M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.